Neimeth International Pharma
Fundamental Profile & Historical Analysis · NGX-Listed Equity
₦7.10
▼ 0.50 (6.58%)
Close on 23 Oct 2026 · End of day, Nigerian Exchange
Previous close
₦7.60
Day range
₦7.10 – 7.20
52-week range
₦4.95 – 14.70
Volume
881,741
Value traded
₦6.3m
₦7.10Fri, 23 Oct 2026
Closing prices as published by the Nigerian Exchange, not adjusted for dividends, share splits or consolidations. Daily for the last year, weekly before that.
Key Metrics — FY2026
Revenue
—
Profit After Tax
—
Total Assets
₦13.9bn
Total Equity
₦2.8bn
EPS (Basic)
—
Net Margin
—
Return on Equity
—
3-Year Financial History
| Metric | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Revenue / Gross Earnings | — | ₦7.4bn | ₦4.5bn |
| Gross Profit | — | ₦3.1bn | ₦2.0bn |
| Profit After Tax | — | ₦1.0bn | ₦-0.9bn |
| Total Assets | ₦13.9bn | ₦14.0bn | ₦12.0bn |
| Total Equity | ₦2.8bn | ₦2.6bn | ₦1.7bn |
| EPS (Basic, ₦) | — | ₦23.00 | ₦-21.00 |
| Net Margin | — | 13.3% | -19.7% |
| Return on Equity | — | 37.2% | -53.6% |
Source: official filings on file. Figures extracted from audited statements; arithmetic-checked rows only.
Official Filings Index
Links open the source document on the NGX website. TickerNG does not redistribute raw PDFs.
- View on NGX ↗
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 2 - FINANCIAL STATEMENT FOR 2026
Q2 · FY2026 · Filed 29 Jul 2026
- View on NGX ↗
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 1 - FINANCIAL STATEMENT FOR 2026
Q1 · FY2026 · Filed 30 Apr 2026
- View on NGX ↗
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC - AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
Annual Report · FY2025 · Filed 29 Mar 2026
- View on NGX ↗
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 3 - FINANCIAL STATEMENT FOR 2025
Q3 · FY2025 · Filed 30 Oct 2025
- View on NGX ↗
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 2 - FINANCIAL STATEMENT FOR 2025
Q2 · FY2025 · Filed 30 Jul 2025
- View on NGX ↗
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 1 - FINANCIAL STATEMENT FOR 2025
Q1 · FY2025 · Filed 30 Apr 2025
- View on NGX ↗
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- AUDITED FINANCIAL STATEMENT FOR ENDED 31 DEC 2024
Annual Report · FY2024 · Filed 30 Apr 2025
- View on NGX ↗
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 3 - FINANCIAL STATEMENT FOR 2024
Q3 · FY2024 · Filed 30 Oct 2024
- View on NGX ↗
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 2 - FINANCIAL STATEMENT FOR 2024
Q2 · FY2024 · Filed 1 Aug 2024
- View on NGX ↗
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 1 - FINANCIAL STATEMENT FOR 2024
Q1 · FY2024 · Filed 30 May 2024
Run a live verification on NEIMETH
Multi-specialist AI analysis — fundamentals, news, macro, sentiment, and a contrarian challenge — synthesised into a sourced investment thesis in under 2 minutes.
Verify NEIMETH on TickerNG →Free tier available. No credit card required.